Poland· PL-100366360

Xanderla

A goserelin product containing goserelinum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.

ATC L02AE03

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about goserelinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Goserelin is registered in 12 of 19 countries.

Countries holding a registration under ATC L02AE03 (goserelin), each read from that country’s own register.

This record: Poland, from URPL (Poland)
8 of them publish a price we can compare per daily dose

Search goserelin products by name

Goserelin · ATC L02AE03

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of goserelin costs, country by country.

Normalised to the WHO defined daily dose (0.129 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Goserelin · price per daily dose (0.129 mg)

USD · FX 28 Sept 2026

CH Switzerland$5.39

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Goserelinum
Manufacturer: Teva Pharmaceuticals Polska Sp. z o.o.
Country: Poland (PL)
ATC code: L02AE03
ATC class: Goserelin
Defined daily dose: 0.129 mg, Implantat
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 3

1 priced

gtin
05909991335564
1 amp.-strzyk.
PLN 177.5
gtin
05909991335571
gtin
05909991335588

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

461 interactions on record for goserelin.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check goserelin against other medicines How interaction checks work

Goserelin · interactions on record

461 records

71 severe
250 moderate
3 minor
137 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Goserelin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All goserelin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Zoladex Depot
Belgium · Zoladex, Zoladex Long Acting
Bulgaria · Золадекс, Золадекс Lа
Cyprus · Zoladex
Czechia · Reseligo, Zoladex Depot
Germany · Goserelin Endomedica, Gosgon
Denmark · Zoladex
Estonia · Reseligo, Zoladex
Spain · Zoladex, Zoladex Trimestral
Finland · Zoladex
France · Zoladex
United Kingdom (Northern Ireland) · Zoladex, Zoladex La
Greece · Implandex, Implandex La
Croatia · Reseligo, Zoladex
Hungary · Reseligo, Zildalis
Ireland · Zoladex, Zoladex La
Iceland · Reseligo, Zoladex
Italy · Zoladex
Lithuania · Algonad, Reseligo
Luxembourg · Zoladex, Zoladex Long Acting
Latvia · Reseligo
Malta · Golexin, Golexin La
Netherlands · Zoladex
Norway · Zoladex
Portugal · Golexin, Golexin La
Romania · Reseligo, Zoladex
Sweden · Zoladex
Slovenia · Reseligo, Zoladex
Slovakia · Reseligo, Zoladex Depot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/367e0dbc-5f32-4fe2-a073-ca8cbd69b664
GET /v1/drugs/367e0dbc-5f32-4fe2-a073-ca8cbd69b664?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Implant w ampułko-strzykawce",
  "source": "urpl",
  "strength": "3,6 mg",
  "packaging": "05909991335564 ¦ Rp ¦ 123208\n1 amp.-strzyk. 3,6 mg\n05909991335571 ¦ Rp ¦ 123209\n2 amp.-strzyk. 3,6 mg\n05909991335588 ¦ Rp ¦ 123210\n3 amp.-strzyk. 3,6 mg",
  "substance": "Goserelini acetas 4,1 mg (w postacji Goserelinum 3,6 mg)",
  "common_name": "Goserelinum",
  "pl_product_id": "100366360",
  "pozwolenie_nr": "24306",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about goserelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console